Breast implants as a possible etiology of epithelioid hemangioendothelioma and successful therapy with interferon-α2

Breast Journal

Volumn 11, Issue 4, 2005, Pages 257-261

  De Wilton Marsh, Robert ^a   Walker, Maryann Hermione ^a   Jacob, George ^b   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Breast implants; Epithelioid hemangioendothelioma; Interferon 2

Indexed keywords

ALPHA2 INTERFERON; CONTRAST MEDIUM; METHOTREXATE; POLYURETHAN; SILICON; VINYL CHLORIDE;

ADULT; ARTICLE; BREAST CANCER; BREAST ENDOPROSTHESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; FEMALE; HEMANGIOENDOTHELIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER NODULE; LIVER TRANSPLANTATION; LUNG NODULE; MASTECTOMY; RARE DISEASE; RISK FACTOR;

ANTINEOPLASTIC AGENTS; BREAST IMPLANTS; FEMALE; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; SILICONE ELASTOMERS;

EID: 22644434003     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21663.x     Document Type: Article

References (27)

1. Uchimura K, Nakamuta M, Osoegawa M, et al. Hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol 2001;32:431-34.
2. Ishak KG, Sesterenn IA, Goodman MZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984;15:839-52.
3. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970-81.
4. Dail D, Liebow A, Gmelich J, et al. Intravascular, bronchiolar and alveolar tumor of the lung (IVBAT). Cancer 1983;51:452-64.
5. Gelin M, Van de Stadt J, Rickaert F, et al. Epithelioid hemangioendothelioma of the liver following contact with vinyl chloride. J Hepatol 1989;8:99-110.
6. Myung S, Carpenter J, Ho KJ. Epithelioid hemangioendothelioma: CT manifestations and possible linkage to vinyl chloride exposure. J Comput Assist Tomogr 1991;15:505-7.
7. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1990. A 15-year-old girl with multiple radiolucent bony defects and multiple pulmonary nodules. N Engl J Med 1990;322:683-90.
8. Lauffer JM, Zimmermann A, Krahenbuhl L, Triller J, Baer HU. Epithelioid hemangioendothelioma of the liver. Cancer 1996;78:2318-27.
9. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver. Cancer 1999;85:562-82.
10. Kelleher M, Iwatsuki S, Sheahan D. Epithelioid hemangioendothelioma of the liver. Clinicopathologic correlation of 10 cases treated by orthotopic liver transplantation. Am J Surg Pathol 1989;13:999-1008.
11. Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 2003;27:48-57.
12. Higgins J, Montgomery B, Wang L, et al. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays. Am J Surg Pathol 2003;27:58-64.
13. Winer E, Fee-Fulkerson K, Fulkerson C, et al. Silicone controversy: a survey of women with breast cancer and silicone implants. J Natl Cancer Inst 1993;85:1407-11.
14. Brinton L, Brown S. Breast implants and cancer. J Natl Cancer Inst 1997;89:1341-49.
15. Lyburn I, Torreggiani W, Harris A, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT and MR imaging appearances. AJR Am J Roentgenol 2003;180:1359-64.
16. Wang B, Chang B, Sargeant R, Manson P. Late capsular hematoma after breast reconstruction with polyurethane-covered implants. Plast Reconstr Surg 1998;102:450-52.
17. Chan S, Birdsell D, Gradeen C. Urinary excretion of free toluenediamines in a patient with polyurethane covered breast implants. Clin Chem 1991;37:2143-45.
18. Sepai O, Henschler D, Czech S, Eckert P, Sabbioni G. Exposure to toluenediamines from polyurethane-covered breast implants. Toxicol Lett 1995;77:371-78.
19. Pinet C, Magnan A, Garbe L, Payan MJ, Vervloet D. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur Respir J 1999;1:237-38.
20. Idilman R, Dokmeci A, Beyler AR, et al. Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology 1997;54:171-75.
21. Ledson MJ, Convery R, Carty A, Evans CC. Epithelioid hemangioendothelioma. Thorax 1999;54:560-61.
22. Holley MP, Cuschieri A. Epithelioid hemangioendothelioma of the liver: objective response to hepatic intra-arterial 5-FU. Eur J Surg Oncol 1989;15:73-78.
23. Kumar P, Ladas GP, Judson I, Nicholson AG. Epithelioid hemangioendothelioma and other vascular mediastinal tumors: a role for alpha-2a Interferon? Ann Thorac Surg 2003;76:653.
24. Roudier-Pujol C, Enjolras O, Lacronique J, et al. Mulifocal epithelioid hemangioendothelioma with partial remission after interferon alfa-2a treatment. Ann Dermatol Venereol 1994;121:898-904.
25. Kayler L, Merion R, Arenas J, et al. Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2b. Transplantation 2002;74:128-30.
26. Hale KL. Interferon: the evolution of a biological therapy. M D Anderson Oncol 1994;39(4):1-3.
27. Ben-Haim M, Roayaie S, Ye M, et al. Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transplant Surg 1999;5:526-31.